Researcher.Life Logo

Oncogematologiya : Impact Factor & More

eISSN: 2413-4023pISSN: 1818-8346
JournalOpen Access

Key Metrics

CiteScore
0.4
SJR
Q4Oncology
SNIP
0.29
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Oncogematologiya

Oncogematologiya Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ABV-press Publishing house, LLC
Language Russian
Publication Time10
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageRussian
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 10
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Oncogematologiya ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Oncogematologiya

Results of treatment for patients with newly diagnosed Hodgkin lymphoma in the Republic of Sakha (Yakutia)
  • 9 Mar 2026
  • Oncohematology
Ph-positive and <i>BCR::ABL1</i>-like acute lymphoblastic leukemia in children
  • 9 Mar 2026
  • Oncohematology
What’s the price for the best? Pharmacoeconomic comparison of asciminib and imatinib in first line of chronic myelogenous leukemia treatment
  • 9 Mar 2026
  • Oncohematology
Treatment of lymphoblastic lymphomas in children in Russia: preliminary results of a multicenter retrospective study
  • 9 Mar 2026
  • Oncohematology
Characteristics and dynamics of the residual tumor clone determined by multicolor flow cytometry in Waldenstrom’s macroglobulinemia
  • 9 Mar 2026
  • Oncohematology
Evolution of approaches to follicular lymphoma therapy at disease onset and first relapse Twenty-five-year experience of the National Medical Research Center for Hematology
  • 9 Mar 2026
  • Oncohematology
Results of treatment for patients with newly diagnosed Hodgkin lymphoma in the Republic of Sakha (Yakutia)
  • 9 Mar 2026
  • Oncohematology
Ph-positive and <i>BCR::ABL1</i>-like acute lymphoblastic leukemia in children
  • 9 Mar 2026
  • Oncohematology
What’s the price for the best? Pharmacoeconomic comparison of asciminib and imatinib in first line of chronic myelogenous leukemia treatment
  • 9 Mar 2026
  • Oncohematology
Treatment of lymphoblastic lymphomas in children in Russia: preliminary results of a multicenter retrospective study
  • 9 Mar 2026
  • Oncohematology
Characteristics and dynamics of the residual tumor clone determined by multicolor flow cytometry in Waldenstrom’s macroglobulinemia
  • 9 Mar 2026
  • Oncohematology
Evolution of approaches to follicular lymphoma therapy at disease onset and first relapse Twenty-five-year experience of the National Medical Research Center for Hematology
  • 9 Mar 2026
  • Oncohematology

FAQs on Oncogematologiya